Advanced Search


Study ID Status Title Patient Level Data
108712 Completed An open-label, 2-period, sequential treatment, drug interaction study to evaluate the effect of low-dose ritonavir on buproprion pharmacokinetics in healthy volunteers
108745 Completed Systematische Dokumentation von Patienten mit akutem HIT-Verdacht
108760 Completed Immunogenicity & safety study of GSK Biologicals’ 208136 vaccine formulated with new measles and rubella working seeds Study Listed on
108835 Completed An Open Label, Multicentre Study to Evaluate Patient Satisfaction with Fluticasone/Salmeterol HFA MDI with Counter in Adult Subjects (18 years of age and older) with Asthma or COPD.
108844 Relinquished Study VEG108844, A study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
108862 Completed Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients with Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
108886 Completed A Phase IV, single centre, open-label study, to investigate the persistence of antibody 6 years after priming immunization with meningococcal conjugate vaccine and indiction of long term immunological memory by assessing persistence of memory B cells and response to the Hib-MenC (Menitorix) vaccine
108888 Completed FondaparinUx Trial with Unfractionated Heparin (UFH) during Revascularization in Acute Coronary Syndromes (ACS) (FUTURA). A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with Unstable Angina/Non ST segment elevation myocardial infarction (UA/NSTEMI) initially treated with subcutaneous fondaparinux and referred for early coronary angiography (OASIS 8) Study Listed on
108890 Completed A Phase I, open-label, vaccination study to evaluate the safety and immunogenicity of the GSK Biologicals recombinant CMV gB sub-unit vaccine GSK1492903A in CMV-seronegative healthy male adult subjects
108919 Relinquished A Randomized, Open-Label, Phase III Study of Taxane Based Chemotherapy with Lapatinib or Trastuzumab as First-Line Therapy for Women with HER2/neu Positive Metastatic Breast Cancer
108933 Completed Phase IIIb, Observer-blind Study to Compare Immunogenicity of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Versus Gardasil® [Quadrivalent Human Papillomavirus (HPV-6,11,16,18 L1 VLP) Recombinant Vaccine Merck & Co., Inc.] Study Listed on
108984 Completed To Evaluate Immune Response to a Hepatitis B Vaccine (Engerix™-B ) Challenge Dose in Healthy Subjects Who Received GSK Biologicals' Hepatitis B Vaccine (Engerix™-B ) Approximately 20 Years Ago as Primary Vaccination at 0, 1, 2 and 12 Months. Study Listed on
108988 Completed Administration of a challenge dose of hepatitis B vaccine in subjects who previously received Engerix™-B vaccine. Study Listed on
109035 Completed A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of GSK163090 in Subjects with Major Depressive Disorder Study Listed on
109059 Completed A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Study Listed on
109063 Relinquished Non-inferiority of GSK Biologicals’ meningococcal vaccine 134612 given concomitantly with GSK Biologicals’ Twinrix™ versus 134612 alone and Twinrix™ alone in healthy subjects aged 11 through 17 years. Study Listed on
109067 Relinquished Lot-to-Lot Consistency, Non-Inferiority Versus Mencevax™ and Evaluation of the co-Administration With Fluarix™ of GSK Biologicals' Meningococcal Vaccine GSK134612, in Healthy Subjects Aged 18 Through 55 Years of Age Study Listed on
109069 Relinquished Primary vaccination study in subjects aged 11-17 years to demonstrate the non-inferiority of GSK Biologicals' Meningococcal vaccine GSK134612 vaccine versus Mencevax™ ACWY Study Listed on
109179 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV vaccine GSK580299 administered according to an alternative dosing schedule as compared to the standard dosing schedule in young female subjects aged 15-25 years Study Listed on
109216 Completed Immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) liquid vaccine (GSK 357941A) in healthy infants. Study Listed on
109275 Completed An Open-Label, Single Sequence Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects with Metastatic ErbB2 Positive Breast Cancer
109315 Completed A Retrospective Study of Healthcare Utilization and Costs of Step-Down Therapy in Asthma Patients Receiving Fluticasone Propionate/Salmeterol Combination
109326 Completed Veramyst vs. other Rx's in managed care
109350 Completed A Multicentre, Randomized, Open-label Study to Evaluate the Efficacy andSafety of Fondaparinux versus Low Molecular Weight Heparin(Nadroparin) in Patients Requiring Rigid or Semi-rigid Immobilization for at least 21 Days and up to 45 Days because of Isolated Non-surgical Below-Knee Injury
109375 Relinquished Study to assess immunogenicity, reactogenicity and safety of primary vaccination with GSK Biologicals' MenACWY vaccine (GSK134612) given as 1 or 2 doses to healthy toddlers 9-12 months of age Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.